Condensed Consolidated Statements of Earnings - USD ($) $ in Millions	3 Months Ended
Mar. 31, 2024	Mar. 31, 2023
Income Statement [Abstract]
Net revenues	$ 5,576	$ 5,719
Cost of sales	1,437	1,434
Excise taxes on products	859	956
Gross profit	3,280	3,329
Marketing, administration and research costs	606	572
Operating income	2,674	2,757
Interest and other debt expense, net	254	229
Net periodic benefit income, excluding service cost	(24)	(31)
(Income) losses from investments in equity securities	(295)	80
Earnings before income taxes	2,739	2,479
Provision for income taxes	610	692
Net earnings	$ 2,129	$ 1,787
Per share data:
Basic earnings per share (in usd per share)	$ 1.21	$ 1.00
Diluted earnings per share (in usd per share)	$ 1.21	$ 1.00

Gain (Loss) From Equity Securities

No definition available.

Name:	mo_GainLossFromEquitySecurities
Namespace Prefix:	mo_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	duration

- Definition

The aggregate total costs related to selling a firm's product and services, as well as research and development costs and all other general and administrative expenses. Direct selling expenses (for example, credit, warranty, and advertising) are expenses that can be directly linked to the sale of specific products. Indirect selling expenses are expenses that cannot be directly linked to the sale of specific products, for example telephone expenses, Internet, and postal charges. Research and development costs represent the aggregate costs incurred during an accounting period to research and develop new products/technologies when the technological feasibility has not been reached. General and administrative expenses include salaries of nonsales personnel, rent, utilities, communication, etc.

+ References

No definition available.